nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—Pyelonephritis—Vandetanib—thyroid cancer	0.0189	0.0588	CcSEcCtD
L-Glutamine—TGM2—neck—thyroid cancer	0.0138	0.0326	CbGeAlD
L-Glutamine—Nail disorder—Vandetanib—thyroid cancer	0.0111	0.0344	CcSEcCtD
L-Glutamine—QARS—neck—thyroid cancer	0.0109	0.0257	CbGeAlD
L-Glutamine—CTPS1—saliva-secreting gland—thyroid cancer	0.0102	0.024	CbGeAlD
L-Glutamine—PFAS—saliva-secreting gland—thyroid cancer	0.00999	0.0235	CbGeAlD
L-Glutamine—Laryngitis—Vandetanib—thyroid cancer	0.00994	0.031	CcSEcCtD
L-Glutamine—Fungal infection—Vandetanib—thyroid cancer	0.00928	0.0289	CcSEcCtD
L-Glutamine—PFAS—Afatinib—Vandetanib—thyroid cancer	0.00925	0.507	CbGdCrCtD
L-Glutamine—CTPS1—Afatinib—Vandetanib—thyroid cancer	0.00898	0.493	CbGdCrCtD
L-Glutamine—F13A1—saliva-secreting gland—thyroid cancer	0.00896	0.0211	CbGeAlD
L-Glutamine—Nephrolithiasis—Vandetanib—thyroid cancer	0.00892	0.0278	CcSEcCtD
L-Glutamine—SLC38A3—thyroid gland—thyroid cancer	0.00879	0.0207	CbGeAlD
L-Glutamine—QARS—saliva-secreting gland—thyroid cancer	0.00852	0.0201	CbGeAlD
L-Glutamine—TGM2—trachea—thyroid cancer	0.00833	0.0196	CbGeAlD
L-Glutamine—TGM1—head—thyroid cancer	0.00798	0.0188	CbGeAlD
L-Glutamine—SLC7A8—neck—thyroid cancer	0.00779	0.0184	CbGeAlD
L-Glutamine—NADSYN1—thyroid gland—thyroid cancer	0.00771	0.0182	CbGeAlD
L-Glutamine—GLS2—thyroid gland—thyroid cancer	0.00771	0.0182	CbGeAlD
L-Glutamine—GFPT2—trachea—thyroid cancer	0.0077	0.0182	CbGeAlD
L-Glutamine—PFAS—trachea—thyroid cancer	0.0077	0.0182	CbGeAlD
L-Glutamine—TGM3—head—thyroid cancer	0.00748	0.0176	CbGeAlD
L-Glutamine—CCBL1—thyroid gland—thyroid cancer	0.00707	0.0167	CbGeAlD
L-Glutamine—GATB—thyroid gland—thyroid cancer	0.00707	0.0167	CbGeAlD
L-Glutamine—F13A1—trachea—thyroid cancer	0.00691	0.0163	CbGeAlD
L-Glutamine—GLS2—head—thyroid cancer	0.00684	0.0161	CbGeAlD
L-Glutamine—NADSYN1—head—thyroid cancer	0.00684	0.0161	CbGeAlD
L-Glutamine—SLC1A5—saliva-secreting gland—thyroid cancer	0.00675	0.0159	CbGeAlD
L-Glutamine—GLS—thyroid gland—thyroid cancer	0.00666	0.0157	CbGeAlD
L-Glutamine—TGM2—thyroid gland—thyroid cancer	0.00659	0.0155	CbGeAlD
L-Glutamine—QARS—trachea—thyroid cancer	0.00657	0.0155	CbGeAlD
L-Glutamine—GATB—head—thyroid cancer	0.00628	0.0148	CbGeAlD
L-Glutamine—CCBL1—head—thyroid cancer	0.00628	0.0148	CbGeAlD
L-Glutamine—Sepsis—Vandetanib—thyroid cancer	0.00622	0.0194	CcSEcCtD
L-Glutamine—CTPS1—thyroid gland—thyroid cancer	0.00621	0.0146	CbGeAlD
L-Glutamine—GMPS—thyroid gland—thyroid cancer	0.00621	0.0146	CbGeAlD
L-Glutamine—GFPT2—thyroid gland—thyroid cancer	0.00609	0.0144	CbGeAlD
L-Glutamine—PFAS—thyroid gland—thyroid cancer	0.00609	0.0144	CbGeAlD
L-Glutamine—GLUL—neck—thyroid cancer	0.00606	0.0143	CbGeAlD
L-Glutamine—GLS—head—thyroid cancer	0.00591	0.0139	CbGeAlD
L-Glutamine—TGM2—head—thyroid cancer	0.00585	0.0138	CbGeAlD
L-Glutamine—ASNS—saliva-secreting gland—thyroid cancer	0.00579	0.0136	CbGeAlD
L-Glutamine—TGM1—lymph node—thyroid cancer	0.00559	0.0132	CbGeAlD
L-Glutamine—CTPS1—head—thyroid cancer	0.00551	0.013	CbGeAlD
L-Glutamine—GMPS—head—thyroid cancer	0.00551	0.013	CbGeAlD
L-Glutamine—F13A1—thyroid gland—thyroid cancer	0.00547	0.0129	CbGeAlD
L-Glutamine—PFAS—head—thyroid cancer	0.00541	0.0127	CbGeAlD
L-Glutamine—SLC1A5—trachea—thyroid cancer	0.0052	0.0123	CbGeAlD
L-Glutamine—QARS—thyroid gland—thyroid cancer	0.0052	0.0123	CbGeAlD
L-Glutamine—F13A1—head—thyroid cancer	0.00485	0.0114	CbGeAlD
L-Glutamine—Dehydration—Vandetanib—thyroid cancer	0.00484	0.0151	CcSEcCtD
L-Glutamine—Rectal tenesmus—Epirubicin—thyroid cancer	0.0048	0.0149	CcSEcCtD
L-Glutamine—CAD—thyroid gland—thyroid cancer	0.00479	0.0113	CbGeAlD
L-Glutamine—NADSYN1—lymph node—thyroid cancer	0.00479	0.0113	CbGeAlD
L-Glutamine—GLS2—lymph node—thyroid cancer	0.00479	0.0113	CbGeAlD
L-Glutamine—GLUL—saliva-secreting gland—thyroid cancer	0.00473	0.0111	CbGeAlD
L-Glutamine—SLC16A10—neck—thyroid cancer	0.00462	0.0109	CbGeAlD
L-Glutamine—QARS—head—thyroid cancer	0.00461	0.0109	CbGeAlD
L-Glutamine—ASNS—trachea—thyroid cancer	0.00446	0.0105	CbGeAlD
L-Glutamine—PPAT—thyroid gland—thyroid cancer	0.00445	0.0105	CbGeAlD
L-Glutamine—Rectal tenesmus—Doxorubicin—thyroid cancer	0.00444	0.0138	CcSEcCtD
L-Glutamine—Pancreatitis—Vandetanib—thyroid cancer	0.00441	0.0137	CcSEcCtD
L-Glutamine—GATB—lymph node—thyroid cancer	0.00439	0.0104	CbGeAlD
L-Glutamine—CCBL1—lymph node—thyroid cancer	0.00439	0.0104	CbGeAlD
L-Glutamine—CAD—head—thyroid cancer	0.00425	0.01	CbGeAlD
L-Glutamine—GLS—lymph node—thyroid cancer	0.00414	0.00976	CbGeAlD
L-Glutamine—SLC1A5—thyroid gland—thyroid cancer	0.00412	0.0097	CbGeAlD
L-Glutamine—Hepatic function abnormal—Sorafenib—thyroid cancer	0.00402	0.0125	CcSEcCtD
L-Glutamine—Depression—Vandetanib—thyroid cancer	0.004	0.0125	CcSEcCtD
L-Glutamine—PPAT—head—thyroid cancer	0.00394	0.0093	CbGeAlD
L-Glutamine—CTPS1—lymph node—thyroid cancer	0.00385	0.00909	CbGeAlD
L-Glutamine—GMPS—lymph node—thyroid cancer	0.00385	0.00909	CbGeAlD
L-Glutamine—Proctalgia—Epirubicin—thyroid cancer	0.00381	0.0119	CcSEcCtD
L-Glutamine—GFPT2—lymph node—thyroid cancer	0.00379	0.00892	CbGeAlD
L-Glutamine—PFAS—lymph node—thyroid cancer	0.00379	0.00892	CbGeAlD
L-Glutamine—SLC7A8—thyroid gland—thyroid cancer	0.00371	0.00874	CbGeAlD
L-Glutamine—SLC1A5—head—thyroid cancer	0.00365	0.00861	CbGeAlD
L-Glutamine—GLUL—trachea—thyroid cancer	0.00365	0.0086	CbGeAlD
L-Glutamine—Urinary tract disorder—Vandetanib—thyroid cancer	0.00355	0.0111	CcSEcCtD
L-Glutamine—ASNS—thyroid gland—thyroid cancer	0.00353	0.00833	CbGeAlD
L-Glutamine—Urethral disorder—Vandetanib—thyroid cancer	0.00353	0.011	CcSEcCtD
L-Glutamine—Proctalgia—Doxorubicin—thyroid cancer	0.00353	0.011	CcSEcCtD
L-Glutamine—F13A1—lymph node—thyroid cancer	0.0034	0.00801	CbGeAlD
L-Glutamine—SLC7A8—head—thyroid cancer	0.00329	0.00775	CbGeAlD
L-Glutamine—Anorectal discomfort—Epirubicin—thyroid cancer	0.00327	0.0102	CcSEcCtD
L-Glutamine—Angiopathy—Vandetanib—thyroid cancer	0.00327	0.0102	CcSEcCtD
L-Glutamine—Dehydration—Sorafenib—thyroid cancer	0.00326	0.0102	CcSEcCtD
L-Glutamine—QARS—lymph node—thyroid cancer	0.00323	0.00761	CbGeAlD
L-Glutamine—Mental disorder—Vandetanib—thyroid cancer	0.00315	0.00983	CcSEcCtD
L-Glutamine—Malnutrition—Vandetanib—thyroid cancer	0.00313	0.00977	CcSEcCtD
L-Glutamine—Gastric ulcer—Epirubicin—thyroid cancer	0.00307	0.00958	CcSEcCtD
L-Glutamine—Anorectal discomfort—Doxorubicin—thyroid cancer	0.00302	0.00942	CcSEcCtD
L-Glutamine—CAD—lymph node—thyroid cancer	0.00298	0.00702	CbGeAlD
L-Glutamine—Pancreatitis—Sorafenib—thyroid cancer	0.00297	0.00927	CcSEcCtD
L-Glutamine—Enlargement abdomen—Epirubicin—thyroid cancer	0.00297	0.00926	CcSEcCtD
L-Glutamine—GLUL—thyroid gland—thyroid cancer	0.00288	0.0068	CbGeAlD
L-Glutamine—Gastric ulcer—Doxorubicin—thyroid cancer	0.00284	0.00887	CcSEcCtD
L-Glutamine—PPAT—lymph node—thyroid cancer	0.00276	0.00651	CbGeAlD
L-Glutamine—Nail disorder—Epirubicin—thyroid cancer	0.00275	0.00859	CcSEcCtD
L-Glutamine—Enlargement abdomen—Doxorubicin—thyroid cancer	0.00275	0.00857	CcSEcCtD
L-Glutamine—Arthralgia—Vandetanib—thyroid cancer	0.00267	0.00831	CcSEcCtD
L-Glutamine—Chest pain—Vandetanib—thyroid cancer	0.00267	0.00831	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.00265	0.00826	CcSEcCtD
L-Glutamine—Dry mouth—Vandetanib—thyroid cancer	0.00261	0.00813	CcSEcCtD
L-Glutamine—GLUL—head—thyroid cancer	0.00256	0.00603	CbGeAlD
L-Glutamine—Oedema—Vandetanib—thyroid cancer	0.00256	0.00797	CcSEcCtD
L-Glutamine—SLC1A5—lymph node—thyroid cancer	0.00256	0.00603	CbGeAlD
L-Glutamine—Nail disorder—Doxorubicin—thyroid cancer	0.00255	0.00794	CcSEcCtD
L-Glutamine—Infection—Vandetanib—thyroid cancer	0.00254	0.00792	CcSEcCtD
L-Glutamine—Laryngitis—Epirubicin—thyroid cancer	0.00248	0.00773	CcSEcCtD
L-Glutamine—Urinary tract disorder—Sorafenib—thyroid cancer	0.0024	0.00747	CcSEcCtD
L-Glutamine—Urethral disorder—Sorafenib—thyroid cancer	0.00238	0.00742	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00233	0.00726	CcSEcCtD
L-Glutamine—Fungal infection—Epirubicin—thyroid cancer	0.00231	0.00721	CcSEcCtD
L-Glutamine—Insomnia—Vandetanib—thyroid cancer	0.00231	0.00721	CcSEcCtD
L-Glutamine—SLC7A8—lymph node—thyroid cancer	0.0023	0.00543	CbGeAlD
L-Glutamine—Laryngitis—Doxorubicin—thyroid cancer	0.00229	0.00715	CcSEcCtD
L-Glutamine—Fatigue—Vandetanib—thyroid cancer	0.0022	0.00687	CcSEcCtD
L-Glutamine—Angiopathy—Sorafenib—thyroid cancer	0.0022	0.00687	CcSEcCtD
L-Glutamine—SLC16A10—thyroid gland—thyroid cancer	0.0022	0.00519	CbGeAlD
L-Glutamine—ASNS—lymph node—thyroid cancer	0.00219	0.00517	CbGeAlD
L-Glutamine—Rigors—Epirubicin—thyroid cancer	0.00219	0.00682	CcSEcCtD
L-Glutamine—Injection site pain—Epirubicin—thyroid cancer	0.00219	0.00682	CcSEcCtD
L-Glutamine—Pain—Vandetanib—thyroid cancer	0.00219	0.00682	CcSEcCtD
L-Glutamine—Constipation—Vandetanib—thyroid cancer	0.00219	0.00682	CcSEcCtD
L-Glutamine—Fungal infection—Doxorubicin—thyroid cancer	0.00214	0.00667	CcSEcCtD
L-Glutamine—Mental disorder—Sorafenib—thyroid cancer	0.00213	0.00663	CcSEcCtD
L-Glutamine—Malnutrition—Sorafenib—thyroid cancer	0.00211	0.00659	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00209	0.00652	CcSEcCtD
L-Glutamine—SLC16A10—Amino acid and oligopeptide SLC transporters—SLC5A5—thyroid cancer	0.00205	0.00867	CbGpPWpGaD
L-Glutamine—Breast pain—Epirubicin—thyroid cancer	0.00205	0.00638	CcSEcCtD
L-Glutamine—Rigors—Doxorubicin—thyroid cancer	0.00202	0.00631	CcSEcCtD
L-Glutamine—Injection site pain—Doxorubicin—thyroid cancer	0.00202	0.00631	CcSEcCtD
L-Glutamine—Body temperature increased—Vandetanib—thyroid cancer	0.00202	0.0063	CcSEcCtD
L-Glutamine—Abdominal pain—Vandetanib—thyroid cancer	0.00202	0.0063	CcSEcCtD
L-Glutamine—SLC1A5—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00198	0.00837	CbGpPWpGaD
L-Glutamine—SLC1A5—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00198	0.00837	CbGpPWpGaD
L-Glutamine—Viral infection—Epirubicin—thyroid cancer	0.00198	0.00617	CcSEcCtD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.00196	0.00828	CbGpPWpGaD
L-Glutamine—Breast pain—Doxorubicin—thyroid cancer	0.00189	0.00591	CcSEcCtD
L-Glutamine—GMPS—Metabolism—MINPP1—thyroid cancer	0.00184	0.00776	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—MINPP1—thyroid cancer	0.00184	0.00776	CbGpPWpGaD
L-Glutamine—Asthenia—Vandetanib—thyroid cancer	0.00183	0.00572	CcSEcCtD
L-Glutamine—Viral infection—Doxorubicin—thyroid cancer	0.00183	0.0057	CcSEcCtD
L-Glutamine—Pruritus—Vandetanib—thyroid cancer	0.00181	0.00564	CcSEcCtD
L-Glutamine—Arthralgia—Sorafenib—thyroid cancer	0.0018	0.00561	CcSEcCtD
L-Glutamine—Myalgia—Sorafenib—thyroid cancer	0.0018	0.00561	CcSEcCtD
L-Glutamine—QARS—Gene Expression—TRIM33—thyroid cancer	0.00179	0.00757	CbGpPWpGaD
L-Glutamine—GLUL—lymph node—thyroid cancer	0.00179	0.00422	CbGeAlD
L-Glutamine—Injection site reaction—Epirubicin—thyroid cancer	0.00178	0.00554	CcSEcCtD
L-Glutamine—Dry mouth—Sorafenib—thyroid cancer	0.00176	0.00548	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—NDUFA13—thyroid cancer	0.00175	0.00741	CbGpPWpGaD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—AKT1—thyroid cancer	0.00172	0.00726	CbGpPWpGaD
L-Glutamine—Infection—Sorafenib—thyroid cancer	0.00171	0.00534	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TRIM24—thyroid cancer	0.00171	0.00721	CbGpPWpGaD
L-Glutamine—Candida infection—Epirubicin—thyroid cancer	0.00171	0.00532	CcSEcCtD
L-Glutamine—Dizziness—Vandetanib—thyroid cancer	0.00169	0.00527	CcSEcCtD
L-Glutamine—SLC38A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00168	0.00712	CbGpPWpGaD
L-Glutamine—SLC38A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00168	0.00712	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—MINPP1—thyroid cancer	0.00168	0.0071	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—CHST14—thyroid cancer	0.00165	0.00696	CbGpPWpGaD
L-Glutamine—Injection site reaction—Doxorubicin—thyroid cancer	0.00164	0.00512	CcSEcCtD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—thyroid cancer	0.00163	0.0069	CbGpPWpGaD
L-Glutamine—Vomiting—Vandetanib—thyroid cancer	0.00163	0.00507	CcSEcCtD
L-Glutamine—Rash—Vandetanib—thyroid cancer	0.00161	0.00503	CcSEcCtD
L-Glutamine—Dermatitis—Vandetanib—thyroid cancer	0.00161	0.00502	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CHST14—thyroid cancer	0.00161	0.00678	CbGpPWpGaD
L-Glutamine—Headache—Vandetanib—thyroid cancer	0.0016	0.00499	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—thyroid cancer	0.00158	0.00492	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00157	0.0049	CcSEcCtD
L-Glutamine—PFAS—Metabolism—NDUFA13—thyroid cancer	0.00156	0.0066	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—NDUFA13—thyroid cancer	0.00156	0.0066	CbGpPWpGaD
L-Glutamine—Sepsis—Epirubicin—thyroid cancer	0.00155	0.00483	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TRIM33—thyroid cancer	0.00152	0.00643	CbGpPWpGaD
L-Glutamine—Nausea—Vandetanib—thyroid cancer	0.00152	0.00473	CcSEcCtD
L-Glutamine—CCBL1—Disease—TRIM24—thyroid cancer	0.00149	0.0063	CbGpPWpGaD
L-Glutamine—Fatigue—Sorafenib—thyroid cancer	0.00149	0.00464	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00148	0.00463	CcSEcCtD
L-Glutamine—SLC1A5—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00148	0.00627	CbGpPWpGaD
L-Glutamine—Constipation—Sorafenib—thyroid cancer	0.00148	0.0046	CcSEcCtD
L-Glutamine—Pain—Sorafenib—thyroid cancer	0.00148	0.0046	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—MINPP1—thyroid cancer	0.00147	0.00621	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—MINPP1—thyroid cancer	0.00147	0.00621	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—MINPP1—thyroid cancer	0.00147	0.00621	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CHST14—thyroid cancer	0.00147	0.00621	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—CHST14—thyroid cancer	0.00147	0.00621	CbGpPWpGaD
L-Glutamine—Sepsis—Doxorubicin—thyroid cancer	0.00143	0.00447	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—NDUFA13—thyroid cancer	0.00143	0.00604	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00141	0.0044	CcSEcCtD
L-Glutamine—CCBL1—Disease—CHST14—thyroid cancer	0.0014	0.00593	CbGpPWpGaD
L-Glutamine—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.00137	0.00428	CcSEcCtD
L-Glutamine—SLC16A10—lymph node—thyroid cancer	0.00137	0.00322	CbGeAlD
L-Glutamine—Body temperature increased—Sorafenib—thyroid cancer	0.00136	0.00425	CcSEcCtD
L-Glutamine—Abdominal pain—Sorafenib—thyroid cancer	0.00136	0.00425	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CHST14—thyroid cancer	0.00134	0.00568	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TRIM33—thyroid cancer	0.00133	0.00562	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—HPGD—thyroid cancer	0.00133	0.00561	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—THRB—thyroid cancer	0.0013	0.00547	CbGpPWpGaD
L-Glutamine—ASNS—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00127	0.00538	CbGpPWpGaD
L-Glutamine—GLUL—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00127	0.00538	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Sorafenib—thyroid cancer	0.00127	0.00396	CcSEcCtD
L-Glutamine—SLC38A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00126	0.00533	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PRKAR1A—thyroid cancer	0.00125	0.00528	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—NDUFA13—thyroid cancer	0.00125	0.00528	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NDUFA13—thyroid cancer	0.00125	0.00528	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NDUFA13—thyroid cancer	0.00125	0.00528	CbGpPWpGaD
L-Glutamine—SLC7A8—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00124	0.00526	CbGpPWpGaD
L-Glutamine—SLC7A8—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00124	0.00526	CbGpPWpGaD
L-Glutamine—Asthenia—Sorafenib—thyroid cancer	0.00124	0.00386	CcSEcCtD
L-Glutamine—Pruritus—Sorafenib—thyroid cancer	0.00122	0.0038	CcSEcCtD
L-Glutamine—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.00121	0.0051	CbGpPWpGaD
L-Glutamine—Dehydration—Epirubicin—thyroid cancer	0.00121	0.00376	CcSEcCtD
L-Glutamine—CAD—Metabolism—MINPP1—thyroid cancer	0.00118	0.005	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—HPGD—thyroid cancer	0.00118	0.005	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—HPGD—thyroid cancer	0.00118	0.005	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CHST14—thyroid cancer	0.00117	0.00496	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CHST14—thyroid cancer	0.00117	0.00496	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CHST14—thyroid cancer	0.00117	0.00496	CbGpPWpGaD
L-Glutamine—Dizziness—Sorafenib—thyroid cancer	0.00114	0.00356	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—thyroid cancer	0.00113	0.00352	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—thyroid cancer	0.00112	0.00348	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—thyroid cancer	0.0011	0.00343	CcSEcCtD
L-Glutamine—Vomiting—Sorafenib—thyroid cancer	0.0011	0.00342	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.00109	0.00461	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.00109	0.00461	CbGpPWpGaD
L-Glutamine—Rash—Sorafenib—thyroid cancer	0.00109	0.00339	CcSEcCtD
L-Glutamine—Dermatitis—Sorafenib—thyroid cancer	0.00109	0.00339	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—HPGD—thyroid cancer	0.00108	0.00458	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—MINPP1—thyroid cancer	0.00108	0.00458	CbGpPWpGaD
L-Glutamine—Headache—Sorafenib—thyroid cancer	0.00108	0.00337	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—thyroid cancer	0.00104	0.00325	CcSEcCtD
L-Glutamine—Nausea—Sorafenib—thyroid cancer	0.00102	0.00319	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—thyroid cancer	0.00102	0.00317	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TCF7L1—thyroid cancer	0.00102	0.00429	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—NDUFA13—thyroid cancer	0.00101	0.00425	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—TPR—thyroid cancer	0.00101	0.00425	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—CP—thyroid cancer	0.00101	0.00425	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000991	0.00418	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00098	0.00305	CcSEcCtD
L-Glutamine—CAD—Metabolism—CHST14—thyroid cancer	0.000947	0.004	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—HPGD—thyroid cancer	0.000947	0.004	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—HPGD—thyroid cancer	0.000947	0.004	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—HPGD—thyroid cancer	0.000947	0.004	CbGpPWpGaD
L-Glutamine—SLC7A8—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000932	0.00393	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—NDUFA13—thyroid cancer	0.000921	0.00389	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000907	0.00283	CcSEcCtD
L-Glutamine—Rhinitis—Epirubicin—thyroid cancer	0.0009	0.0028	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—thyroid cancer	0.000891	0.00278	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—thyroid cancer	0.000888	0.00375	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TCF7L1—thyroid cancer	0.000887	0.00375	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Epirubicin—thyroid cancer	0.000886	0.00276	CcSEcCtD
L-Glutamine—Urethral disorder—Epirubicin—thyroid cancer	0.00088	0.00274	CcSEcCtD
L-Glutamine—QARS—Gene Expression—TPR—thyroid cancer	0.000875	0.0037	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CHST14—thyroid cancer	0.000866	0.00366	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000856	0.00362	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000856	0.00362	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MINPP1—thyroid cancer	0.000844	0.00357	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MINPP1—thyroid cancer	0.000844	0.00357	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000842	0.00356	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—BRAF—thyroid cancer	0.000835	0.00353	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—BRAF—thyroid cancer	0.000835	0.00353	CbGpPWpGaD
L-Glutamine—Rhinitis—Doxorubicin—thyroid cancer	0.000832	0.00259	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—IFNA2—thyroid cancer	0.000829	0.0035	CbGpPWpGaD
L-Glutamine—Pharyngitis—Doxorubicin—thyroid cancer	0.000824	0.00257	CcSEcCtD
L-Glutamine—QARS—Gene Expression—MEN1—thyroid cancer	0.000823	0.00347	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00082	0.00256	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—thyroid cancer	0.000814	0.00254	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—thyroid cancer	0.000814	0.00254	CcSEcCtD
L-Glutamine—Chills—Epirubicin—thyroid cancer	0.000805	0.00251	CcSEcCtD
L-Glutamine—Mental disorder—Epirubicin—thyroid cancer	0.000786	0.00245	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—thyroid cancer	0.000781	0.00243	CcSEcCtD
L-Glutamine—Flatulence—Epirubicin—thyroid cancer	0.00077	0.0024	CcSEcCtD
L-Glutamine—CAD—Metabolism—HPGD—thyroid cancer	0.000763	0.00322	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—TPR—thyroid cancer	0.000763	0.00322	CbGpPWpGaD
L-Glutamine—Back pain—Epirubicin—thyroid cancer	0.000756	0.00235	CcSEcCtD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000754	0.00318	CbGpPWpGaD
L-Glutamine—Angiopathy—Doxorubicin—thyroid cancer	0.000753	0.00235	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—PRKAR1A—thyroid cancer	0.000751	0.00317	CbGpPWpGaD
L-Glutamine—Chills—Doxorubicin—thyroid cancer	0.000745	0.00232	CcSEcCtD
L-Glutamine—NADSYN1—Disease—TPR—thyroid cancer	0.000743	0.00314	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NRAS—thyroid cancer	0.000733	0.00309	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PRKAR1A—thyroid cancer	0.000731	0.00309	CbGpPWpGaD
L-Glutamine—Mental disorder—Doxorubicin—thyroid cancer	0.000727	0.00227	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—thyroid cancer	0.000725	0.00226	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—thyroid cancer	0.000723	0.00225	CcSEcCtD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000722	0.00305	CbGpPWpGaD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000722	0.00305	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PRKAR1A—thyroid cancer	0.000719	0.00304	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NDUFA13—thyroid cancer	0.000718	0.00303	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NDUFA13—thyroid cancer	0.000718	0.00303	CbGpPWpGaD
L-Glutamine—Flatulence—Doxorubicin—thyroid cancer	0.000712	0.00222	CcSEcCtD
L-Glutamine—Malaise—Epirubicin—thyroid cancer	0.000704	0.0022	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—thyroid cancer	0.000699	0.00218	CcSEcCtD
L-Glutamine—NADSYN1—Disease—MEN1—thyroid cancer	0.000699	0.00295	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—HPGD—thyroid cancer	0.000698	0.00295	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—TPR—thyroid cancer	0.00068	0.00287	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—TPR—thyroid cancer	0.00068	0.00287	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CHST14—thyroid cancer	0.000675	0.00285	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CHST14—thyroid cancer	0.000675	0.00285	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000671	0.00209	CcSEcCtD
L-Glutamine—PFAS—Metabolism—PRKAR1A—thyroid cancer	0.000669	0.00283	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PRKAR1A—thyroid cancer	0.000669	0.00283	CbGpPWpGaD
L-Glutamine—Chest pain—Epirubicin—thyroid cancer	0.000665	0.00207	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—thyroid cancer	0.000665	0.00207	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—thyroid cancer	0.000665	0.00207	CcSEcCtD
L-Glutamine—Discomfort—Epirubicin—thyroid cancer	0.000657	0.00205	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—NRAS—thyroid cancer	0.000655	0.00277	CbGpPWpGaD
L-Glutamine—Malaise—Doxorubicin—thyroid cancer	0.000652	0.00203	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—thyroid cancer	0.00065	0.00203	CcSEcCtD
L-Glutamine—CCBL1—Disease—TPR—thyroid cancer	0.00065	0.00274	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000641	0.00271	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PRKAR1A—thyroid cancer	0.000639	0.0027	CbGpPWpGaD
L-Glutamine—Oedema—Epirubicin—thyroid cancer	0.000637	0.00199	CcSEcCtD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000633	0.00267	CbGpPWpGaD
L-Glutamine—Infection—Epirubicin—thyroid cancer	0.000633	0.00197	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—CP—thyroid cancer	0.000632	0.00267	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000632	0.00267	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—KRAS—thyroid cancer	0.00063	0.00266	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000626	0.00264	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—TPR—thyroid cancer	0.000622	0.00263	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000622	0.00263	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Epirubicin—thyroid cancer	0.000616	0.00192	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—thyroid cancer	0.000615	0.00192	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—thyroid cancer	0.000615	0.00192	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—thyroid cancer	0.000615	0.00192	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—PRKAR1A—thyroid cancer	0.000612	0.00259	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MEN1—thyroid cancer	0.000611	0.00258	CbGpPWpGaD
L-Glutamine—Discomfort—Doxorubicin—thyroid cancer	0.000608	0.00189	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—thyroid cancer	0.000602	0.00188	CcSEcCtD
L-Glutamine—Oedema—Doxorubicin—thyroid cancer	0.00059	0.00184	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—thyroid cancer	0.000586	0.00183	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000581	0.00181	CcSEcCtD
L-Glutamine—Insomnia—Epirubicin—thyroid cancer	0.000577	0.0018	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—SLC5A5—thyroid cancer	0.000571	0.00241	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00057	0.00178	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—KRAS—thyroid cancer	0.000564	0.00238	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CALCA—thyroid cancer	0.000556	0.00235	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—RXRA—thyroid cancer	0.00055	0.00232	CbGpPWpGaD
L-Glutamine—Fatigue—Epirubicin—thyroid cancer	0.00055	0.00171	CcSEcCtD
L-Glutamine—Constipation—Epirubicin—thyroid cancer	0.000545	0.0017	CcSEcCtD
L-Glutamine—Pain—Epirubicin—thyroid cancer	0.000545	0.0017	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—TPR—thyroid cancer	0.000544	0.0023	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—TPR—thyroid cancer	0.000544	0.0023	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—TPR—thyroid cancer	0.000544	0.0023	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—HPGD—thyroid cancer	0.000544	0.0023	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HPGD—thyroid cancer	0.000544	0.0023	CbGpPWpGaD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00054	0.00228	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000539	0.00227	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000537	0.00167	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—HRAS—thyroid cancer	0.000536	0.00226	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PRKAR1A—thyroid cancer	0.000535	0.00226	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PRKAR1A—thyroid cancer	0.000535	0.00226	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PRKAR1A—thyroid cancer	0.000535	0.00226	CbGpPWpGaD
L-Glutamine—Insomnia—Doxorubicin—thyroid cancer	0.000533	0.00166	CcSEcCtD
L-Glutamine—Feeling abnormal—Epirubicin—thyroid cancer	0.000525	0.00164	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000521	0.00162	CcSEcCtD
L-Glutamine—GMPS—Metabolism—SLC5A5—thyroid cancer	0.000509	0.00215	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—SLC5A5—thyroid cancer	0.000509	0.00215	CbGpPWpGaD
L-Glutamine—Fatigue—Doxorubicin—thyroid cancer	0.000509	0.00158	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—thyroid cancer	0.000504	0.00157	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—thyroid cancer	0.000504	0.00157	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—thyroid cancer	0.000504	0.00157	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—thyroid cancer	0.000504	0.00157	CcSEcCtD
L-Glutamine—NADSYN1—Disease—CDK1—thyroid cancer	0.000504	0.00213	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000501	0.00212	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000501	0.00212	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CALCA—thyroid cancer	0.000486	0.00205	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Doxorubicin—thyroid cancer	0.000486	0.00151	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000482	0.0015	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—RXRA—thyroid cancer	0.00048	0.00203	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—BRAF—thyroid cancer	0.00048	0.00203	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—thyroid cancer	0.000479	0.00202	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IFNA2—thyroid cancer	0.000476	0.00201	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000473	0.002	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—AKT1—thyroid cancer	0.000473	0.002	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Epirubicin—thyroid cancer	0.00047	0.00146	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—thyroid cancer	0.000466	0.00145	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—thyroid cancer	0.000466	0.00145	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—SLC5A5—thyroid cancer	0.000466	0.00197	CbGpPWpGaD
L-Glutamine—Asthenia—Epirubicin—thyroid cancer	0.000457	0.00143	CcSEcCtD
L-Glutamine—Pruritus—Epirubicin—thyroid cancer	0.000451	0.00141	CcSEcCtD
L-Glutamine—CCBL1—Disease—CDK1—thyroid cancer	0.00044	0.00186	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—TPR—thyroid cancer	0.000438	0.00185	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—thyroid cancer	0.000435	0.00135	CcSEcCtD
L-Glutamine—CAD—Metabolism—PRKAR1A—thyroid cancer	0.000431	0.00182	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—RXRA—thyroid cancer	0.000428	0.00181	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—RXRA—thyroid cancer	0.000428	0.00181	CbGpPWpGaD
L-Glutamine—Asthenia—Doxorubicin—thyroid cancer	0.000423	0.00132	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—thyroid cancer	0.000422	0.00131	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—thyroid cancer	0.000417	0.0013	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—SLC5A5—thyroid cancer	0.000407	0.00172	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—SLC5A5—thyroid cancer	0.000407	0.00172	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—SLC5A5—thyroid cancer	0.000407	0.00172	CbGpPWpGaD
L-Glutamine—Vomiting—Epirubicin—thyroid cancer	0.000405	0.00126	CcSEcCtD
L-Glutamine—NADSYN1—Disease—NRG1—thyroid cancer	0.000404	0.00171	CbGpPWpGaD
L-Glutamine—Rash—Epirubicin—thyroid cancer	0.000402	0.00125	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—thyroid cancer	0.000402	0.00125	CcSEcCtD
L-Glutamine—PPAT—Metabolism—TPR—thyroid cancer	0.000401	0.00169	CbGpPWpGaD
L-Glutamine—Headache—Epirubicin—thyroid cancer	0.000399	0.00124	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000398	0.00168	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PRKAR1A—thyroid cancer	0.000395	0.00167	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—RXRA—thyroid cancer	0.000391	0.00165	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—thyroid cancer	0.00039	0.00122	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000387	0.00164	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—HRAS—thyroid cancer	0.000384	0.00162	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—thyroid cancer	0.000384	0.00162	CbGpPWpGaD
L-Glutamine—Nausea—Epirubicin—thyroid cancer	0.000379	0.00118	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—thyroid cancer	0.000375	0.00117	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—thyroid cancer	0.000372	0.00116	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—thyroid cancer	0.000372	0.00116	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—thyroid cancer	0.00037	0.00115	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000367	0.00155	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—CP—thyroid cancer	0.000367	0.00155	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—TERT—thyroid cancer	0.000363	0.00153	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000361	0.00152	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRG1—thyroid cancer	0.000353	0.00149	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—thyroid cancer	0.00035	0.00109	CcSEcCtD
L-Glutamine—QARS—Gene Expression—PPARG—thyroid cancer	0.000348	0.00147	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HIF1A—thyroid cancer	0.000347	0.00147	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—RXRA—thyroid cancer	0.000342	0.00144	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—RXRA—thyroid cancer	0.000342	0.00144	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—RXRA—thyroid cancer	0.000342	0.00144	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—SLC5A5—thyroid cancer	0.000328	0.00139	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—TERT—thyroid cancer	0.000317	0.00134	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TPR—thyroid cancer	0.000312	0.00132	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TPR—thyroid cancer	0.000312	0.00132	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NRAS—thyroid cancer	0.000309	0.00131	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PRKAR1A—thyroid cancer	0.000307	0.0013	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PRKAR1A—thyroid cancer	0.000307	0.0013	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HIF1A—thyroid cancer	0.000303	0.00128	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PPARG—thyroid cancer	0.000303	0.00128	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SLC5A5—thyroid cancer	0.0003	0.00127	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—thyroid cancer	0.000288	0.00122	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—BRAF—thyroid cancer	0.000287	0.00121	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—RXRA—thyroid cancer	0.000276	0.00116	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000274	0.00116	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PPARG—thyroid cancer	0.00027	0.00114	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PPARG—thyroid cancer	0.00027	0.00114	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—KRAS—thyroid cancer	0.000266	0.00112	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—RXRA—thyroid cancer	0.000252	0.00107	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—BRAF—thyroid cancer	0.000251	0.00106	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PPARG—thyroid cancer	0.000247	0.00104	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—thyroid cancer	0.000238	0.00101	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—thyroid cancer	0.000236	0.000999	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC5A5—thyroid cancer	0.000234	0.000988	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC5A5—thyroid cancer	0.000234	0.000988	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—thyroid cancer	0.000232	0.00098	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000231	0.000974	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—thyroid cancer	0.000226	0.000955	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—thyroid cancer	0.000221	0.000932	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PPARG—thyroid cancer	0.000216	0.000912	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PPARG—thyroid cancer	0.000216	0.000912	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PPARG—thyroid cancer	0.000216	0.000912	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—thyroid cancer	0.000213	0.000898	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—thyroid cancer	0.000213	0.000898	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTEN—thyroid cancer	0.000208	0.000878	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—thyroid cancer	0.000203	0.000857	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTEN—thyroid cancer	0.000202	0.000855	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—thyroid cancer	0.0002	0.000843	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—RXRA—thyroid cancer	0.000197	0.00083	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—RXRA—thyroid cancer	0.000197	0.00083	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—thyroid cancer	0.000194	0.000821	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTEN—thyroid cancer	0.000185	0.000783	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTEN—thyroid cancer	0.000185	0.000783	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—thyroid cancer	0.000181	0.000763	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—thyroid cancer	0.000178	0.00075	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTEN—thyroid cancer	0.000177	0.000747	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PPARG—thyroid cancer	0.000174	0.000735	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—thyroid cancer	0.00017	0.000718	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—thyroid cancer	0.00017	0.000718	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—thyroid cancer	0.00017	0.000718	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTEN—thyroid cancer	0.00017	0.000716	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PPARG—thyroid cancer	0.000159	0.000673	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—thyroid cancer	0.000158	0.000667	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KRAS—thyroid cancer	0.000155	0.000657	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—KRAS—thyroid cancer	0.000153	0.000645	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTEN—thyroid cancer	0.000148	0.000626	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTEN—thyroid cancer	0.000148	0.000626	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTEN—thyroid cancer	0.000148	0.000626	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—thyroid cancer	0.000137	0.00058	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—thyroid cancer	0.000137	0.000579	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KRAS—thyroid cancer	0.000136	0.000574	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—thyroid cancer	0.000136	0.000574	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—thyroid cancer	0.000132	0.000558	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—thyroid cancer	0.00013	0.000549	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—thyroid cancer	0.000125	0.000529	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PPARG—thyroid cancer	0.000124	0.000524	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PPARG—thyroid cancer	0.000124	0.000524	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—thyroid cancer	0.00012	0.000506	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTEN—thyroid cancer	0.000119	0.000505	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—thyroid cancer	0.000117	0.000493	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—thyroid cancer	0.000115	0.000488	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—thyroid cancer	0.000115	0.000484	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTEN—thyroid cancer	0.000109	0.000461	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—thyroid cancer	0.000107	0.000451	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—thyroid cancer	0.000107	0.000451	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—thyroid cancer	0.000102	0.000431	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—thyroid cancer	9.77e-05	0.000413	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—thyroid cancer	9.76e-05	0.000412	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—thyroid cancer	9.76e-05	0.000412	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—thyroid cancer	8.54e-05	0.000361	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—thyroid cancer	8.54e-05	0.000361	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—thyroid cancer	8.54e-05	0.000361	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTEN—thyroid cancer	8.51e-05	0.000359	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTEN—thyroid cancer	8.51e-05	0.000359	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—thyroid cancer	6.88e-05	0.000291	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—thyroid cancer	6.3e-05	0.000266	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—thyroid cancer	4.91e-05	0.000207	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—thyroid cancer	4.91e-05	0.000207	CbGpPWpGaD
